(Q42267838)

19 October 2017

Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteers (English)

1 reference

19 October 2017

Azizi M

1

1 reference

19 October 2017

Veyssier-Belot C

2

1 reference

19 October 2017

Alhenc-Gelas M

3

1 reference

19 October 2017

Chatellier G

4

1 reference

19 October 2017

Billaud-Mesguish E

5

1 reference

19 October 2017

Fiessinger JN

6

1 reference

19 October 2017

Aiach M

7

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

British Journal of Clinical Pharmacology

19 October 2017

1 reference

19 October 2017

40

1 reference

19 October 2017

6

1 reference

19 October 2017

577-584

1 reference

Low molecular weight heparin therapy: is monitoring needed?

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

Relationship between biological activity and concentration of a low-molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

Comparison of the pharmacokinetic profiles of three low molecular mass heparins--dalteparin, enoxaparin and nadroparin--administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism).

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365214

The mode of action of CY216 and CY222 in plasma

17 August 2018

1 reference

12 December 2020

On the relationship between molecular mass and anticoagulant activity in a low molecular weight heparin (enoxaparin)

1 reference

12 December 2020

Microbubble-induced phospholipase C activation does not correlate with platelet aggregation

1 reference

12 December 2020

Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential

1 reference

12 December 2020

Symptomatic hereditary type-II protein C deficiency caused by a missense mutation in exon IX of the protein C gene (Gly381 to Ser)

1 reference

12 December 2020

Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group

1 reference

12 December 2020

A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers

1 reference

12 December 2020

Identifiers

1 reference

19 October 2017

PubMed publication ID

8703665

1 reference